Page 1 of Clinical Trials for OSI Pharmaceuticals [SPONSOR-COLLABORATORS], 75 Total Matches
- 1CompletedLast Updated: February 17, 2006Condition(s): Gastroesophageal Adenocarcinoma; Gastric Adenocarcinoma
- 2CompletedLast Updated: March 13, 2007Condition(s): Locally Recurrent or Metastatic Cancer of the Head and Neck; Must Have Failed First-Line Therapy
- 3CompletedLast Updated: November 8, 2011Condition(s): Advanced Solid Tumors
- 4Enrolling by invitationLast Updated: February 29, 2012Condition(s): Ependymoma
- 5Active, not recruitingLast Updated: March 9, 2012Condition(s): Non-small Cell Lung Cancer
- 6CompletedLast Updated: November 21, 2011Condition(s): Advanced Non Small Cell Lung Cancer; Failed Prior Chemotherapy
- 7CompletedLast Updated: November 8, 2011Condition(s): NSCLC
- 8CompletedLast Updated: June 30, 2011Condition(s): Non-Small Cell Lung Cancer
- 9CompletedLast Updated: March 12, 2012Condition(s): Advanced Pancreatic Cancer
- 10CompletedLast Updated: November 8, 2011Condition(s): Carcinoma, Non-small-cell Lung
- 11CompletedLast Updated: June 30, 2011Condition(s): Carcinoma, Non-Small-Cell Lung
- 12CompletedLast Updated: February 17, 2006Condition(s): Locally Advanced or Metastatic Adenoca of the Biliary Tract
- 13RecruitingLast Updated: February 29, 2012Condition(s): Recurrent or Refractory Pediatric Ependymoma
- 14CompletedLast Updated: November 8, 2011Condition(s): Pancreatic Cancer
- 15CompletedLast Updated: January 16, 2009Condition(s): Advanced Solid Tumors
- 16CompletedLast Updated: July 23, 2008Condition(s): Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- 17Active, not recruitingLast Updated: January 3, 2012Condition(s): Metastatic Colorectal Cancer
- 18CompletedLast Updated: October 18, 2011Condition(s): Ovarian Neoplasms
- 19Active, not recruitingLast Updated: March 1, 2012Condition(s): Carcinoma, Non-Small-Cell Lung
- 20Active, not recruitingLast Updated: February 20, 2008Condition(s): Prostate Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=OSI+Pharmaceuticals
